If you need more lookups,
subscriptions start at $34 USD/month.
Alison Schecter Location
Cambridge, MA, US
Alison Schecter Work
2026 -now Chief Medical Officer @ Retension Pharmaceuticals
2025 -2026 SVP, Clinical Development @
2023 -2025 Chief Executive Officer @ Molecules to Medicine Advisory Group
2021 -2023 President of Research and Development @ Axcella Therapeutics
2019 -2020 CMO @
2017 -2019 Global Project Head @
2015 -2017 Global Program Head, Hemophilia @
2014 -2015 Vice President Of Business Development in Cardiovascular Disease and Heart Failure @
2008 -2013 Executive Director @
Alison Schecter Education
Mount Sinai School of Medicine of New York University
(Cardiology Research Fellowship)
1995-1996
Harvard Medical School 1993-1995
The Johns Hopkins University School of Medicine 1990-1993
Alison Schecter Summary
Alison Schecter, based in Cambridge, MA, US, is currently a Chief Medical Officer at Retension Pharmaceuticals. Alison Schecter brings experience from previous roles at Mineralys Therapeutics, Inc., Molecules to Medicine Advisory Group, Axcella Therapeutics and Selecta Biosciences. Alison Schecter holds a 1995 - 1996 Mount Sinai School of Medicine of New York University. Alison Schecter has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Alison Schecter?
Find contact details for 700 million professionals.